Constellation Pharmaceuticals is a clinical-stage biopharmaceutical company using epigenetics for the development of therapeutics for the selective targeting and modulating of gene expression in tumor and immune cells.
Timeline
October 1, 2019
Constellation Pharmaceuticals raises a $65,000,000 venture round.
July 1, 2017
Constellation Pharmaceuticals raises a $48,500,000 series E round from The Column Group, Third Rock Ventures, Topspin Partners and Venrock.
December 9, 2015
Constellation Pharmaceuticals raises a $55,000,000 series E round from Solon Mack Capital, The Column Group, Third Rock Ventures, Topspin Partners and Venrock.
August 6, 2014
Constellation Pharmaceuticals raises a $5,000,000 series D round.
January 17, 2012
Constellation Pharmaceuticals raises a $95,000,000 series C round from Genentech.
June 2011
Constellation Pharmaceuticals raises a $15,000,000 series B round from Altitude Life Science Ventures, Sr One, The Column Group, Third Rock Ventures and Venrock.
June 7, 2010
Constellation Pharmaceuticals raises a $22,300,000 series B round from Altitude Life Science Ventures, Sr One, The Column Group, Third Rock Ventures and Venrock.
August 13, 2009
Constellation Pharmaceuticals raises a $17,200,000 series B round from Altitude Life Science Ventures, The Column, Third Rock Ventures and Venrock.
Funding rounds
Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
100,000,000
April 2018
55,000,000
December 9, 2015
15,000,000
June 2011
17,200,000
August 13, 2009
48,500,000
July 1, 2017
22,300,000
June 7, 2010
65,000,000
October 1, 2019
95,000,000
January 17, 2012
People
Name
Role
LinkedIn
Bill Bradley
Employee
Mark Lodish
Investor
Michael Cooper
Employee
Michael Hewitt
Employee
Natasha Girgis
Employee
Further reading
Title
Author
Link
Type
Date
Documentaries, videos and podcasts
Title
Date
Link
Companies
Company
CEO
Location
Products/Services
References
Is a
Company attributes
Company status
Active
B2X
Founder
Crunchbase
Legal name
Constellation Pharmaceuticals, Inc.
Legal classification
Number of Employees (ranges)
100–249
Tagline
Translating stellar science into breakthrough medicines
Full address
215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
CIK number
Place of incorporation
Founded date
2008
Email address
info@constellationpharma.com
Phone number
617-714-0555
Fax number
(617) 577-0472
Total funding amount (USD)
423,000,000
Latest funding round date
October 1, 2019
Business model
Commerce
Stock symbol
CSNT
Stock exchange
